Home page Navigation Content Search

Breadcrumb Navigation

Portrait Verena Bossung

Verena Bossung
PD Dr. med.

Attending Physician, Department of Obstetrics

Specialties

  • Focus on special obstetrics and perinatal medicine (D)
  • External turns from pelvic presentation/transverse position, imminent premature birth
  • International Board Certified Lactation Consultant (IBCLC)

Departments

Contact

Tel. +41 44 255 11 11

Other competencies

  • DEGUM I
  • Master of Health Business Administration (MHBA), FAU Nuremberg
  • Teaching at the Medical Faculty of the University of Lübeck, Germany
  • Invasive and non-invasive prenatal diagnostics

Career

since 03/2022 Attending Physician, Department of Obstetrics, University Hospital Zurich
2016 – 2021 Attending Physician, Head of Obstetrics, University Medical Center Schleswig-Holstein, Lübeck Campus
2018 – 2020 Master of Health Business Administration (MHBA, part-time), FAU Nuremberg
12/2017 Specialization in special obstetrics and perinatal medicine (DE)
12/2016 International Board Certified Lactation Consultant (IBCLC), recertified 2021
2014 – 2015 Gynecologist, University Medical Center Schleswig-Holstein, Campus Lübeck
02/2014 Specialist in gynecology and obstetrics (DE)
2012 – 2014 Resident, Gynecological Clinic, University Hospital Schleswig-Holstein, Lübeck Campus
2007 – 2011 Resident, Gynecological Clinic, University Hospital Cologne
2008 Doctorate (Dr. med.), University of Hamburg
2000 – 2007 Medical studies and license to practice medicine, University of Hamburg

Most important memberships

  • German Society for Gynecology and Obstetrics (DGGG)
  • Working Group for Obstetrics and Perinatal Medicine in the DGGG (AGG)
  • German Society for Perinatal Medicine (DGPM)
  • German Society for Ultrasound in Medicine (DEGUM)
  • German Medical Association (DÄB)

Research focus

  • Interventions in the event of a threatened premature birth
  • Peripartum microbiome in mother and child
  • Influence of pregnancy factors on the neonatal outcome of very small preterm infants

  • Bossung, V., & Harbeck, N. (2010). Angiogenesis inhibitors in the management of breast cancer. Current opinion in obstetrics & gynecology, 22(1), 79-86. Review.
  • Thadhani, R., Kisner, T., Hagmann, H., Bossung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O. A., Kreyssig, C., Hemphill, L., Rigby, A. C., Khedkar, S., Lindner, T. H., Mallmann, P., Stepan, H., Karumanchi, S. A., & Benzing, T. (2011). Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation, 124(8), 940-950.
  • Hagmann, H.#, Bossung, V.#, Belaidi, A. A., Fridman, A., Karumanchi, S. A., Thadhani, R., Schermer, B., Mallmann, P., Schwarz, G., Benzing, T., & Brinkkoetter, P. T. (2014). Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination. PloS one, 9(1), e85258. (# contributed equally)
  • Gevensleben, H. #, Bossung, V. #, Meindl, A., Wappenschmidt, B., de Gregorio, N., Osorio, A., Romero, A., Buettner, R., Markiefka, B., & Schmutzler, R. K. (2014). Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers. Virchows Archiv: an international journal of pathology, 465(3), 365-369. (# contributed equally)
  • Bossung V. Molecular basis of premature rupture of the bladder. In Rody A, Liedtke C. Molecular gynecology and obstetrics for practice. 2016. Stuttgart: Georg Thieme Verlag, 55-60
  • Humberg, A., Härtel, C., Paul, P., Hanke, K., Bossung, V., Hartz, A., Fasel, L., Rausch, T. K., Rody, A., Herting, E., Göpel, W., & German Neonatal Network (GNN) (2017). Delivery mode and intraventricular hemorrhage risk in very-low-birth-weight infants: Observational data of the German Neonatal Network. European journal of obstetrics, gynecology, and reproductive biology, 212, 144-149.
  • Astiz, M., Heyde, I., Fortmann, M. I., Bossung, V., Roll, C., Stein, A., Grüttner, B., Göpel, W., Härtel, C., Obleser, J., Oster, H. (2020). The circadian phase of antenatal glucocorticoid treatment affects the risk of behavioral disorders. Nature communications, 11(1), 3593.
  • Bossung, V., Fortmann, M. I., Fusch, C., Rausch, T., Herting, E., Swoboda, I., Rody, A., Härtel, C., Göpel, W., & Humberg, A. (2020). Neonatal Outcome After Preeclampsia and HELLP Syndrome: A Population-Based Cohort Study in Germany. Frontiers in pediatrics, 8, 579293.
  • Matlac, D., Jonassen, S., Fortmann, M., Rody, A., Bossung, V. (2021) A question of timing: 10-year retrospective analysis on the use of antenatal steroids for imminent preterm birth. Z Obstetrics Neonatol. 225(6):493-498.
  • Bossung, V., Rath, W., Rody, A., Schwarz, C. (2021) Heterogenous use of misoprostol for induction of labor. Results of an online survey among midwives in German speaking countries. Arch Gynecol Obstet. 304(6):1501-1511.
  • Bossung, V., Rath, W., Rody, A., Schwarz, C. (2021) Heterogenous use of misoprostol for induction of labor. Results of an online survey among midwives in German speaking countries. Arch Gynecol Obstet. 304(6):1501-1511.
  • Bossung, V., Lupatsii, M., Dashdorj, L., Tassiello, O., Jonassen, S., Pagel, J., Demmert, M., Wolf, EA., Rody, A., Waschina, S., Graspeuntner, S., Rupp, J., Härtel, C. (2022)Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants. Gut Microbes. 14(1):2038855.
  • Fortmann, I., Mertens, L., Böckel, H., Grüttner, B., Humberg, A., Astiz, M., Roll, C., Ricklefs, I., Rody, A., Härtel, C., Herting, E., Göpel, W., Bossung, V. for the German Neonatal Network (GNN). A timely administration of antenatal steroids is highly protective against intraventricular hemorrhage: An observational multicenter cohort study of very low birthweight infants. (accepted for publication)